SUMITOMO PHARMA CO LTD: SUMITOMO PHARMA AMERICA ANNOUNCES FIRST PATIENT RECEIVES TREATMENT IN PHASE 1/2A STUDY FOR INVESTIGATIONAL THERAPY DSP-3077 FOR RETINITIS PIGMENTOSA

Reuters · 2d ago

Please log in to view news